Miao Qinfang, Hua Sha, Gong Yiwen, Lyu Zhenfeng, Qian Pengfang, Liu Chun, Jin Wei, Hu Peng, Qi Haikun
School of Biomedical Engineering, ShanghaiTech University, Shanghai, China; Shanghai Clinical Research and Trial Center, Shanghai, China.
Department of Cardiovascular Medicine, Heart Failure Center, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Cardiovasc Magn Reson. 2024;26(2):101093. doi: 10.1016/j.jocmr.2024.101093. Epub 2024 Sep 6.
Myocardial fibrosis is a common feature in various cardiac diseases. It causes adverse cardiac remodeling and is associated with poor clinical outcomes. Late gadolinium enhancement (LGE) and extracellular volume fraction (ECV) are the standard magnetic resonance imaging techniques for detecting focal and diffuse myocardial fibrosis. However, these contrast-enhanced techniques require the administration of gadolinium contrast agents, which is not applicable to patients with gadolinium contraindications. To eliminate the need for contrast agents, we developed and applied an endogenous free-breathing T1ρ dispersion imaging technique (FB-MultiMap) for diagnosing diffuse myocardial fibrosis in a cohort with suspected cardiomyopathies.
The proposed FB-MultiMap technique, enabling T2, T1ρ, and their difference (myocardial fibrosis index [mFI]) quantification in a single scan was developed in phantoms and 15 healthy subjects. In the clinical study, 55 patients with suspected cardiomyopathies were imaged using FB-MultiMap, conventional native T1 mapping, LGE, and ECV imaging. The accuracy of the endogenous parameters for predicting increased ECV was evaluated using receiver operating characteristic curve analysis. In addition, the correlation of native T1, T1ρ, and mFI with ECV was, respectively, assessed using Pearson correlation coefficients.
FB-MultiMap showed a good agreement with conventional separate breath-hold mapping techniques in phantoms and healthy subjects. Considering all the patients, T1ρ was more accurate than mFI and native T1 for predicting increased ECV, with area under the curve (AUC) values of 0.91, 0.79, and 0.75, respectively, and showed a stronger correlation with ECV (correlation coefficient r: 0.72 vs 0.52 vs 0.40). In the subset of 47 patients with normal T2 values, the diagnostic performance of mFI was significantly strengthened (AUC = 0.90, r = 0.83), outperforming T1ρ and native T1.
The proposed free-breathing T1ρ dispersion imaging technique enabling simultaneous quantification of T2, T1ρ, and mFI in a single scan has shown great potential for diagnosing diffuse myocardial fibrosis in patients with complex cardiomyopathies without contrast agents.
心肌纤维化是各种心脏疾病的常见特征。它会导致不良的心脏重塑,并与临床预后不良相关。延迟钆增强(LGE)和细胞外容积分数(ECV)是检测局灶性和弥漫性心肌纤维化的标准磁共振成像技术。然而,这些对比增强技术需要注射钆造影剂,这不适用于有钆造影剂禁忌证的患者。为了消除对造影剂的需求,我们开发并应用了一种内源性自由呼吸T1ρ散相成像技术(FB-MultiMap),用于在一组疑似心肌病患者中诊断弥漫性心肌纤维化。
所提出的FB-MultiMap技术能够在单次扫描中对T2、T1ρ及其差值(心肌纤维化指数[mFI])进行定量,该技术在模型和15名健康受试者中得到了开发。在临床研究中,对55名疑似心肌病患者使用FB-MultiMap、传统的自然T1成像、LGE和ECV成像进行了扫描。使用受试者操作特征曲线分析评估内源性参数预测ECV升高的准确性。此外,分别使用Pearson相关系数评估自然T1、T1ρ和mFI与ECV的相关性。
在模型和健康受试者中,FB-MultiMap与传统的单独屏气成像技术显示出良好的一致性。考虑所有患者,T1ρ在预测ECV升高方面比mFI和自然T1更准确,曲线下面积(AUC)值分别为0.91、0.79和0.75,并且与ECV的相关性更强(相关系数r:0.72对0.52对0.40)。在47名T2值正常的患者亚组中,mFI的诊断性能显著增强(AUC = 0.90,r = 0.83),优于T1ρ和自然T1。
所提出的自由呼吸T1ρ散相成像技术能够在单次扫描中同时对T2、T1ρ和mFI进行定量,在无需造影剂的情况下,对于诊断复杂心肌病患者的弥漫性心肌纤维化显示出巨大潜力。